Involvement of monoaminergic system in antidepressant- like activity of Glycyrrhiza glabra root extracts in rat

Pharmacologyonline

Volumn 2, Issue , 2011, Pages 405-415

  Chowdhury, Bimalendu ^a   Bhattamisra, Subrat Kumar ^a   Das, Mangala Charana ^b  

^a ROLAND INSTITUTE OF PHARMACEUTICAL SCIENCES   (India)

^b NRI Medical College   (India)

Author keywords

Antidepressant effect; Force swim test; Glycyrrhiza glabra; Locomotor activity; Monoamine oxidase; Tail suspension test

Indexed keywords

ALCOHOL; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; GLYCYRRHIZA GLABRA EXTRACT; IMIPRAMINE; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG MEGADOSE; DRUG POTENCY; ENZYME ACTIVITY; EXPERIMENTAL TEST; FEMALE; FORCED SWIMMING TEST; LOCOMOTION; MAXIMUM TOLERATED DOSE; MONOAMINERGIC SYSTEM; NONHUMAN; PHYTOCHEMISTRY; PLANT ROOT; RAT; SOLVENT EXTRACTION; TAIL SUSPENSION TEST;

EID: 80053086782     PISSN: None     EISSN: 18278620     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Gold PW, Goodwin FK, Chrousus GP. Clinical and biochemical manifestations of depression in relation to neurobiology of stress: Part-1. N Engl J Med 1988; 319: 348-353.
2. Rosenzweig-Lipson S, Beyer CE, Hughes ZA, et al. Differentiating antidepressants of the future: Efficacy and safety. Pharmacol Ther 2007; 113: 134-153.
3. Tripathi KD. Essential of Medical Pharmacology, 5th ed. Medical Publishers Pvt. Ltd: New Delhi, 2005:168-172.
4. Tran PV, Bymaster FP, McNamara RK, Potter WZ. Dual monoamine modulation for improved treatment of major depressive disorder. J Cli Psychopharmacol 2003: 23, 78-86.
5. Bhattacharya SK, Bhattacharya A, Sairam K, Ghosal S. Anxiolytic-antidepressant activity of Withania somnifera glycowithanolides: an experimental study. Phytomed 2000; 7: 463-469.
6. Sairam K, Dorababu M, Goel RK, Bhattacharya SK. Antidepressant activity of standardized extract of Bacopa monniera in experimental models of depression in rats. Phytomed 2002; 9: 207-11.
7. Kasper S, Anghelescu IG, Szegedi A, Dienel A, Kieser M. Superior efficacy of St. John's wort extract WS 5570 compared to placebo inpatients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial. BMC Med 2006; 23: 4-14.
8. Ody P. The complete guide medicinal herbal. Dorling Kindersley: London.
9. Obolentseva GV, Litvinenko VI, Ammosov AS, Popova TP, Sampiev AM. Pharmacological and therapeutic properties of licorice preparations (a review). Pharmaceutical Chemistry Journal 1999; 33(8): 427-431.
10. Turpie AG, Thomson TJ. Carbenoxolone sodium in the treatment of gastric ulcer with special reference to side effects. Gut 1965; 6: 591-594.
11. Ambawade SD, Kasture VS, Kasture SB. Anticonvulsant activity of roots and rhizomes of Glycyrrhiza glabra. Indian J Pharmacol 2002; 34: 251-255.
12. Dhingra D, Parle M and Kulkarni SK. Memory enhancing activity of Glycyrrhiza glabra in mice. J Ethnopharmacol 2004; 91: 361-365.
13. Dhingra D and Sharma A. Antidepressant-like activity of Glycyrrhiza glabra L. in mouse models of immobility tests. Prog Neuropsychopharmacol Biol Psychiat 2006; 30: 449-454.
14. Muralidharan P, Balamurugan G, Venu Babu. Cerebroprotective effect of Glycyrrhiza glabra Linn. root extract on Hypoxic rats. Bangladesh J Pharmacol 2009; 4: 60-64.
15. Ecobichon DJ. The basis of toxicology testing RC press: New York, 1997: 43-86.
16. Porsolt R, Jalfre M. Swimming Rats and Human Depression (Reply). Nature 1978; 274: 512-513.
17. Detke MJ, Lucki I. Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depth. Behav Brain Res 1995; 73: 43-6.
18. Sharma VK, Chauhan NS, Lodhi S, Singhai AK. Anti-Depressant Activity of Zizyphus xylopyrus. International Journal of Phytomedicine 2009; l1: 12-17.
19. Pan Y, Kong L, Xia X, Zhang W, Xia W, Jiang F. Antidepressant like effect of icariin and its possible mechanism in mice. Pharmacol Biochem Behav 2005; 82: 686-694.
20. Schurr A, Livne A. Differential inhibition of mitochondrial monoamine oxidase from brain by hashish components. Biochem Pharmacol 1976; 25: 1201-1203.
21. Yu ZF, Kong LD, Chen Y. Antidepressant activity of aqueous extract of Curcuma longa in mice. J Ethinopharmacol 2002; 83: 161-165.
22. Lowry OH, Rosebrough NJ, Farr AL, Randall R. Protein measurement with folin phenol reagent. J Biol Chem 1951; 193: 265-275.
23. Charney DS. Monoamine dysfunction and the pathophysiology and treatment of depression. J Clin Psyc 1998; 59: 11-14.
24. Delgado PL, Moreno FA. Role of norepinephrine in depression. J Clin Psyc 2000; 61: 5-12.
25. Rojas-Corrales MO, Berrecoso E, Gilbert-Rahola J, Mico JA. Antidepressant-like effects of tramadol and other central analgesics with activity on monoamines reuptake, in helpless rats. Life Sci 2002; l72: 143-152.
26. Nestler EJ, Barrot M, Dileone RJ, Gold SJ, Monteggia LM. Neurobilogy of depression. Neuron 2002; 34: 13-25.
27. Steru L, Chermatm R, Thierry B, Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacol 1985; 85: 367-370.
28. Dhingra D, Sharma A. Antidepressant-like activity of Glycyrrhiza glabra L. in mouse model of immobility test. Prog Neuropsychopharmacol Biol Psych 2006; 30: 449-454.
29. Thierry B, Steru L, Simon P, Porsolt RD. The tail suspension test: Ethical considerations. Psychopharmacology (Berl) 1986; 90: 284-285.
30. Petit-Demouliere B, Chenu F, Bourin M. Force swimming test in mice: a review of antidepressant activity. J Psychopharmacol 2005; 177: 245-255.
31. Sherman AD, Sacquitne JL, Petty F. Specificity of the learned helplessness model of depression. Pharmacol Biochem Behav 1982; 16: 449-454.
32. Hemby SE, Lucki I, Gatto G, Singh A, Thornley C, Matasi J. Potential antidepressant effects of novel tropane compounds, selective for serotonin or dopamine transporters. J Pharmacol Exp Ther 1997; 282: 727-733.
33. Wouters J. Structural aspects of monoamine oxidase and its reversible inhibition. Curr Med Chem 1998; 5: 137-162.
34. Knoll J. History of deprenyl-the first selective inhibitor of monoamine oxidase type B. Voprosy Meditsinskoi Khimii 1997; 43: 482-493.
35. nd ed. Washington, DC: American Psychiatric Press, 1998: 239-249.
36. Dar A, Khatoon S. Behavioral and biochemical studies of dichloromethane fraction from the Areca catechu nut. Pharmacol Biochem Behav 2000; 65: 1-6.